1. Home
  2. NBN vs PCRX Comparison

NBN vs PCRX Comparison

Compare NBN & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northeast Bank

NBN

Northeast Bank

HOLD

Current Price

$125.85

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.53

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBN
PCRX
Founded
1872
2006
Country
United States
United States
Employees
234
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
NBN
PCRX
Price
$125.85
$23.53
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$130.50
$30.25
AVG Volume (30 Days)
98.8K
517.6K
Earning Date
04-27-2026
04-30-2026
Dividend Yield
0.03%
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
N/A
$541,533,000.00
Revenue This Year
$13.77
$6.78
Revenue Next Year
$18.72
$8.54
P/E Ratio
$11.29
$338.29
Revenue Growth
N/A
26.04
52 Week Low
$79.26
$18.80
52 Week High
$135.62
$27.64

Technical Indicators

Market Signals
Indicator
NBN
PCRX
Relative Strength Index (RSI) 57.01 49.35
Support Level $115.99 $22.06
Resistance Level $135.62 $24.20
Average True Range (ATR) 3.75 1.04
MACD 0.33 0.06
Stochastic Oscillator 83.29 49.23

Price Performance

Historical Comparison
NBN
PCRX

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: